《柳叶刀》(The Lancet)2015年8月15日目次选登

8/20/2018

小全编辑

全科之窗|ABC平台

1412

8/20/2018 12:00:00 AM

Working towards better health in humanitarian crises
在人道主义危机中向更好的健康发展

Focusing on angina
聚焦心绞痛

In-stent restenosis treatment: quest for the best device
支架内再狭窄的治疗:追求最好的装置

Network meta-analysis: a norm for comparative effectiveness?
网络Meta分析:疗效比较的标准

Open questions for non-infarct-related arteries in STEMI
在急性心肌梗死中非梗死相关动脉的开放式问题

ADVICE on adenosine to improve atrial fibrillation ablation
建议用腺苷改善房颤消融

Antidotes for anticoagulants: a long way to go
抗凝血剂的解毒剂:还有很长的路要走

ISIS and the emergence of large, simple trials
科学与国际安全研究所和涌现出的大型简单的试验

A global perspective on hypertension: a Lancet Commission
关于高血压的全球视角:柳叶刀委员会

Cardiology: a call for papers
心脏病:征稿启事

Health of the UK population in 2040
2040年英国人口健康

Salim Yusuf: global leader in cardiovascular disease research
Salim Yusuf:心血管疾病的全球领导者

Hospital detention practices: statement of a global taskforce
医院拘役实践:全球工作组声明

G7 health commitments: greater specificity for greater accountability
七国集团(G7)卫生承诺:更大的特异性针对更大的责任

Gender disparities in water, sanitation, and global health
性别差异在供水、公共卫生和全球健康

Rhesus disease: a major public health problem
恒河疾病:一个主要公共卫生问题

Parenteral antibiotics are not enough to prevent pneumonia in stroke
肠外抗生素不足以预防卒中肺炎

Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis
支架内再狭窄中的经皮冠状动脉介入治疗策略:一个网络meta分析

Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial
idarucizumab逆转抗凝效果的安全性、耐受性和疗效在健康男性志愿者:一个随机,安慰剂对照,双盲试验第一阶段

Pharmacological and emerging therapies in the treatment of chronic angina
药理和新兴疗法治疗慢性心绞痛

Stable coronary artery disease: revascularisation and invasive strategies
稳定的冠状动脉疾病:血管重塑和侵入性策略

版权所有 ©2018 智医创工具 All Rights Reserved. 沪ICP备12048712号-4